Further study seemed to be necessary, not only in regard to the above problem, but for the practical management of the disease. It appeared to be important to investigate the effect of treatment with corticosteroid drugs and corticotrophin on the adrenal function in these patients.
With these points in mind, it was decided to reassess adrenal function in two groups of the original patients after treatment, one group having received prednisone and the other A.C.T.H.
SUBJECTS AND METHODS
The subjects were patients with continuous asthma in whom the adrenal function had been assessed (Robson and Kilborn, 1965) and in whom corticosteroid or corticotrophin therapy was indicated clinically. The prednisone group consisted of 14 of the first 21 patients to be investigated, and the A.C.T.H. group consisted of the subsequent 13 patients. One patient was excluded from the A.C.T.H. group when she became pregnant. The two groups are comparable for age, sex, duration of asthma, and in their initial response to A.C.T.H. stimulation (Table I) .
The prednisone group received prednisone, 5 mg. t.d.s., for a minimum period of three months, and the A.C.T.H. group received A.C.T.H., 20 units i.m. daily, for a minimum period of two months. The periods of treatment were selected arbitrarily, but it was thought that they were of a sufficient duration to obtain the full effect on the adrenal cortex of the particular treatment.
The methods used have been described in detail previously (Robson and Kilborn, 1965) . They consisted of an estimation of the cortisol production rate by an isotope dilution method, which measures the total mass of metabolites derived from cortisol alone (Cope and Black, 1958; De Witt et al., 1962) , followed by the serial estimation of plasma cortisol during the intravenous infusion of 30 units of A.C.T.H. over eight hours (Cameron and Kilborn, 1964 ug./100 ml., from 16-1 (S.D. +7-6) ug./100 ml.
to 35-9 (S.D.+9-9) ug./100 ml. before treatment.
The difference between the eight-hour levels ug. /100 ml.) is significant (S.E. 3Q2; P<0-005), but the difference between the basal levels (3-0
Mtg./100 ml.) is not significant (S.E. 2-2; P=0-2).
When the results of the 'subnormal' and 'normal' groups are considered separately, there is no significant change in the mean basal levels, the mean decrease in the 'subnormal' group being 3*3 Mug./100 ml. (17-1-13-8 ,ug./100 ml.) and in the 'normal' group 21 ,ug./100 ml. (13-5-11-4 ,ug.!/100 ml.). After eight hours' A.C.T.H. stimulation, the 'subnormal' group showed a fall of 6-1
Mug.!100 ml. after treatment (30 6->24 5 Mug./100 ml.; P 0-01-0-02) and the 'normal' group a fall of 25-2 ig./100 ml. (49-3--241 ,ug./100 ml.).
The 'normal' group is too small for a confident statistical comparison to be made, but it is clear that it accounts for most of the fall of the group as a whole.
Interestingly enough, one patient in the 'subnormal' group showed a small rise in response from 270 ,ug./100 ml. to 33 0 ,ug./100 ml. at eight hours.
Cortisol production rate The mean cortisot production rate before prednisone was 9 0 mg./24 hours, and after treatment 6-5 mg./24 hours, a decrease of 2-5 mg./24 hours. This difference is not significant (S.E. 125; P>0-05). (Fig. 3) . It is not surprising that this is so in the prednisone group, since the response was depressed to similar levels in all cases; but in the A.C.T.H. group there was no relation between the magnitude of change in response and the degree of symptomatic relief. This study was not designed as a clinical trial of any particular treatment, and the improvement obtained in these patients was of the order expected from clinical experience in the use of prednisone and corticotrophin. There were more patients showing greater improvement in the prednisone group; it may be that this difference is due to the prednisone group receiving substitution therapy greater than is needed for physiological requirements, whereas the A.C.T.H. group was dependent on endogenous steroid production for a therapeutic effect.
Most patients in the A.C.T.H. group showed a considerable increase in adrenocortical activity after treatment; this was reflected in the cortisol production rate as well as by the A.C.T.H. response test, although it should be noted that there was no apparent correlation between the individual changes in the cortisol production rates and the A.C.T.H. response tests. The normal mean basal plasma cortisol after treatment may be explained by the fact that it only reflects the situation at an instant in time rather than over 24 hours, and by the wide individual variations in plasma cortisol due to many influences; indeed, although every care was always taken to minimize any anxiety, it is possible that the second response test caused less stress to the patient.
Nevertheless, after prolonged stimulation by A.C.T.H., the adrenal cortex was capable of achieving a normal response in most of these patients. This suggests that the reduction in reserve found in the majority of patients before treatment may be secondary to inadequate stimulation by the anterior pituitary rather than to a primary defect of the adrenal cortex. However, adrenocortical hypertrophy (induced by the treatment) probably plays some part in the increase in response.
In the prednisone group, with the dose of prednisone used (15 mg./day), there was no evidence of adrenal suppression in the resting state, but the A.C. Holub, Wallace, and Jailer (1960) found a normal response to metyrapone in six patients who had received A.C.T.H. therapy for a considerable time.
The functional significance of adrenal hyporesponsiveness is uncertain. It is considered that corticosteroid therapy inhibits endogenous corticotrophin and may depress adrenocortical activity directly (Danowski, Bonessi, Sabeh, Sutton, Webster, and Sarver, 1964) . But Farmer, Hill, Pittman, and Herod (1961) presented evidence that there are two mechanisms concerned with corticotrophin release, one being mediated through the neurohypophysis in response to stress and the other through the pituitary-adrenal 'feed-back system'. Estep, Island, Ney, and Liddle (1963) have shown that response to stress is not affected by the acute administration of cortisol, and they suggest that a stressful situation may override the 'feed-back' mechanism as long as the adrenal cortex is capable of responding to corticotrophin.
It has been widely assumed that one of the major hazards of corticosteroid therapy is an inability to respond to acute stress, but biochemical confirmation of this is confined to a few cases. Indeed, Sampson, Winstone, and Brooke (1962) The significance and practical application of these findings are discussed.
